Category Archives: Depakote

Featured Stories

Actos, Avandia May Up Risk for Diabetic Macular Edema

A newly published study is raising concerns that patients who take Actos or Avandia may face an increased risk of developing diabetic macular edema, an eye disorder that can result in vision loss. The study, published in the Archives of Internal Medicine, found that type 2 diabetics who use thiazolidinediones, ...

Read More

Federal DePuy ASR Hip Implant Trials Likely to Start This Year

It looks as though the first trials in the DePuy ASR hip implant multidistrict litigation could begin sometime later this year. According to a report from Bloomberg News, during a status conference held yesterday in Florida, attorneys for both plaintiffs and the defense told U.S. District Judge David Katz that ...

Read More

Former Executives Accuse Health Technology Firm of Fraud

Former Executives Accuse Health Technology Firm of Fraud

Former NantHealth executives claim that the company made fraudulent claims about the reliability of its system, which links patient information gathered by the devices.

Read More

National Law Firms Calls for More FDA Action on Actos Bladder Cancer Threat

A national law firm is not satisfied with the way the U.S. Food & Drug Administration (FDA) has handled warnings regarding Actos (pioglitazone) bladder cancer risks. In a statement published today, Parker Waichman LLP called on the FDA to compel Takeda Pharmaceuticals, the maker of the type 2 diabetes drug, ...

Read More

Hip Replacement, Knee Implant Patients with Diabetes, Other Health Problems May Face Difficult Recoveries

Patients receiving hip replacement devices or knee implants may face a more complicated recovery if they are obese, or suffer from diabetes or other health woes. According to a new study published online in the journal Anesthesiology, at least 3% of all total hip or knee replacement patients will ...

Read More

Indiana Woman Alleges Serious Injuries From Transvaginal Mesh Products

Parker Waichman LLP, a national law firm, just filed a lawsuit on behalf of a woman who suffered injuries after receiving transvaginal mesh implants. The lawsuit suit alleges that the transvaginal mesh created an unreasonable risk and directly caused her injuries.

Read More

Medtronic Settles Charges Over Kickbacks To Doctors

Medical device giant, Medtronic Inc., is settling charges over kickbacks to doctors. The firms just agreed to pay $23.5 million to settle claims it paid physicians kickbacks in exchange for their use of its pacemakers and defibrillators, according to a U.S. Justice Department announcement yesterday. The company was accused of seeking ...

Read More

Medtronic Infuse Studies Faulted for Downplaying Side Effects

Medtronic Inc.’s published studies for its Infuse bone graft product may have downplayed serious side effects, according to an analysis published last year in The Spine Journal. The study, which drew on U.S. Food & Drug Administration (FDA) documents and other data sources, suggests that up to half of ...

Read More

Study: Epilepsy Drug, Valproate, Linked to Increased Autism Risks

Use of anticonvulsant drug valproate by expectant mothers has been linked to an increased autism risk in their babies, a new study reveals. Valproate is used in the treatment of epilepsy, said the Global Times; however, its use by pregnant … Continue reading

Posted in Depakote, Legal News, Pharmaceuticals |

Abbot Hit With Massive Off-Label Fines

Abbott Laboratories was just hit with a massive fine for off-label practices, the second-largest such criminal fine for a single medication. A federal district judge in Virginia ordered Abbott Laboratories to pay a $500 million criminal fine and a forfeiture … Continue reading

Posted in Depakote, Legal News, Pharmaceuticals |

Lawsuits Claim Abbott Illegally Marketed Depakote

A total of 26 women have recently filed lawsuits claiming the makers of the anti-seizure drug Depakote illegally marketed the drug for off-label purposes and failed to warn of the side effects of the drug. Each of the women, according … Continue reading

Posted in Depakote, Pharmaceuticals | Tagged |

Abbott Pleads Guilty In Depakote Marketing Case, Agrees to Pay $1.5 Billion to Resolve Justice Department Charges

It was announced yesterday that Abbott Laboratories has pleaded guilty in a Depakote marketing case. According to the U.S. Department of Justice, Abbott promoted the drug for nonapproved uses. Depakote (divalproex sodium) is an anti-seizure medication approved to treat epilepsy, … Continue reading

Posted in Depakote, Pharmaceuticals | Tagged |

Depakote Legal Troubles Not Over for Abbott

Depakote continues to pose more legal challenges for Abbott Laboratories (ABT). Among other issues, the company has allegedly violated consumer protection laws in relation to Depakote’s sale and marketing. After allegations of off-market labeling and U.S. Justice Department investigation last … Continue reading

Posted in Depakote, Pharmaceuticals |

Depakote During Pregnancy Linked to Autism Spectrum Disorder

A new study has found more evidence that Depakote may be dangerous to a developing fetus. The study, conducted by Danish researchers, concluded that children who are exposed to valproate, the active ingredient in Depakote, face nearly three times the … Continue reading

Posted in Depakote, Pharmaceuticals |

Pending Depakote Settlement Sparks Abbott Shareholder Lawsuit

Shareholders of Abbott Laboratories have filed a lawsuit stemming from the drug maker’s pending settlement with the federal government over charges it illegally marketed the anti-seizure medication, Depakote (valproic acid), for off-label uses. The lawsuit, which was filed in Illinois … Continue reading

Posted in Depakote, Pharmaceuticals |

Depakote in Pregnancy May Cause Cognitive Impairment

The U.S. Food and Drug Administration (FDA) has warned the public that children born to women who take the anti-seizure medication < "http://www.yourlawyer.com/topics/overview/depakote">Depakote (valproate sodium) or related products (valproic acid and divalproex sodium), when pregnant, may give birth to babies … Continue reading

Posted in Depakote, Pharmaceuticals |

Fetal Exposure to Depakote, Similar Epilepsy Drugs May Impair Cognitive Development

Valproate medications, including < "http://www.yourlawyer.com/topics/overview/Depakote-Lawsuit-Lawyer-Birth-Defects">Depakote, Depakon, Depakene and Stavzor, may negatively impact a child’s IQ if they are taken during pregnancy. The U.S. Food & Drug Administration (FDA) announced yesterday that it will be revising the labels of all valproate … Continue reading

Posted in Depakote, Pharmaceuticals |

Epilepsy Drugs May Up Risk of Pregnancy Complications

Recently, we’ve done quite a bit of reporting on the link between epilepsy drugs like < "http://www.yourlawyer.com/topics/overview/Depakote-Lawsuit-Lawyer-Birth-Defects">Depakote and birth defects. Now a new study finds that such drugs might also increase the risk that pregnant women who take them will … Continue reading

Posted in Depakote, Pharmaceuticals |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.